Robert Hamatake
- Hepatology top 1%
- Hepatitis C virus research 33
- Virology top 2%
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 18
- Epidemiology top 5%
- Hepatitis B Virus Studies 24
- Liver Disease Diagnosis and Treatment 11
- Herpesvirus Infections and Treatments 7
- Molecular Biology top 5%
- DNA Repair Mechanisms 11
-
- Virus-based gene therapy research 6
-
- Bacteriophages and microbial interactions 6
- Co-authors
- Akio SuginoAllan ClarkRichard J. ColonnoZhi HongHiroyuki ArakiAlan MorrisonT.C. ApplebyThomas A. Kunkel
- Journals
- Bioorganic & Medicinal Chemistry Letters (11 papers)Antimicrobial Agents and Chemotherapy (7 papers)Journal of Biological Chemistry (7 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Robert Hamatake
74 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 96
- Hepatology 765
- Virology 261
- Infectious Diseases 593
- Epidemiology 955
- Molecular Biology 1.6k
Countries citing papers authored by Robert Hamatake
This map shows the geographic impact of Robert Hamatake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Hamatake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Hamatake more than expected).
Fields of papers citing papers by Robert Hamatake
This network shows the impact of papers produced by Robert Hamatake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Hamatake. The network helps show where Robert Hamatake may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Hamatake, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 7 | |
| 2 | 2017 | 10 | |
| 3 | 2015 | 42 | |
| 4 | 2012 | 1 | |
| 5 | 2009 | 153 | |
| 6 | RDEA119: A potent and highly selective MEK inhibitor for the treatment of cancer | 2007 | 3 |
| 7 | 2007 | 4 | |
| 8 | 2007 | 20 | |
| 9 | 2007 | 148 | |
| 10 | 2006 | 46 | |
| 11 | 2006 | 32 | |
| 12 | 2006 | 39 | |
| 13 | 2006 | 20 | |
| 14 | Immunology, model systems, and clinical studies | 2004 | 0 |
| 15 | 2003 | 27 | |
| 16 | 1995 | 23 | |
| 17 | 1995 | 7 | |
| 18 | 1991 | 82 | |
| 19 | 1990 | 309 | |
| 20 | 1989 | 68 |
About Robert Hamatake
Robert Hamatake is a scholar working on Hepatology, Virology and Infectious Diseases, having authored 76 papers that have together received 3.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (33 papers), Hepatitis B Virus Studies (24 papers), HIV/AIDS drug development and treatment (18 papers), DNA Repair Mechanisms (11 papers), Liver Disease Diagnosis and Treatment (11 papers), Herpesvirus Infections and Treatments (7 papers), Virus-based gene therapy research (6 papers) and Bacteriophages and microbial interactions (6 papers). The work is most often cited by research in Hepatology (765 citations), Virology (261 citations) and Infectious Diseases (593 citations). Robert Hamatake has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Akio Sugino, Allan Clark, Richard J. Colonno, Zhi Hong, Hiroyuki Araki, Alan Morrison, T.C. Appleby, Thomas A. Kunkel, Christine C. Dykstra and Daniel J. Tenney. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Antimicrobial Agents and Chemotherapy, Journal of Biological Chemistry, Journal of Virology and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.